PubMLST Database home Contents
Log in
Help

Publication breakdown of dataset

Filter query by
Display
  • records per page
Action

22 records returned. Click the hyperlinks for detailed information.

PubMed idYearCitationTitle Isolates in database
218386172012Lott TJ, Frade JP, Lyon GM, Iqbal N, Lockhart SR (2012) Med Mycol 50: 136-42 Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities.
201900712010Lott TJ, Frade JP, Lockhart SR (2010) Eukaryot Cell 9: 619-25 Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies.
146629652003Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ (2003) J Clin Microbiol 41: 5709-17 Multilocus sequence typing of Candida glabrata reveals geographically enriched clades.
303970682019Bordallo-Cardona MÁ, Agnelli C, Gómez-Nuñez A, Sánchez-Carrillo C, Bouza E, Muñoz P, Escribano P, Guinea J (2019) Antimicrob Agents Chemother 63: MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata.
157078442005Dodgson AR, Pujol C, Pfaller MA, Denning DW, Soll DR (2005) Fungal Genet Biol 42: 233-43 Evidence for recombination in Candida glabrata.
284820762018Amanloo S, Shams-Ghahfarokhi M, Ghahri M, Razzaghi-Abyaneh M (2018) Med Mycol 56: 207-215 Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile.
310598312019Guo X, Zhang R, Li Y, Wang Z, Ishchuk OP, Ahmad KM, Wee J, Piskur J, Shapiro JA, Gu Z (2019) Methods [Epub ahead of print]: Understand the genomic diversity and evolution of fungal pathogen Candida glabrata by genome-wide analysis of genetic variations.
305970522019Mushi MF, Gross U, Mshana SE, Bader O (2019) Med Mycol 57: 914-917 High diversity of Candida glabrata in a tertiary hospital-Mwanza, Tanzania.
280183232016Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS (2016) Front Microbiol 7: 1995 Genetic Drivers of Multidrug Resistance in Candida glabrata.
312852292019Rivero-Menendez O, Soto-Debran JC, Medina N, Lucio J, Mellado E, Alastruey-Izquierdo A (2019) Antimicrob Agents Chemother 63: Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain.
292496612018Carreté L, Ksiezopolska E, Pegueroles C, Gómez-Molero E, Saus E, Iraola-Guzmán S, Loska D, Bader O, Fairhead C, Gabaldón T (2018) Curr Biol 28: 15-27.e7 Patterns of Genomic Variation in the Opportunistic Pathogen Candida glabrata Suggest the Existence of Mating and a Secondary Association with Humans.
295806472018Sasso M, Normand AC, Pantel A, Bourgeois N, Lachaud L (2018) J Mycol Med 28: 320-326 Evaluation of the DiversiLab® automated repetitive sequence-based PCR system for the characterization of Candida albicans and Candida glabrata isolates.
283441622017Biswas C, Chen SC, Halliday C, Kennedy K, Playford EG, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V (2017) Clin Microbiol Infect 23: 676.e7-676.e10 Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
176447142007Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NA, Jones BL (2007) J Med Microbiol 56: 1066-75 One year prospective survey of Candida bloodstream infections in Scotland.
282800172017Håvelsrud OE, Gaustad P (2017) Genome Announc 5: Draft Genome Sequences of Candida glabrata Isolates 1A, 1B, 2A, 2B, 3A, and 3B.
304552472019Ahmad S, Joseph L, Parker JE, Asadzadeh M, Kelly SL, Meis JF, Khan Z (2019) Antimicrob Agents Chemother 63: ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.
308092002019Carreté L, Ksiezopolska E, Gómez-Molero E, Angoulvant A, Bader O, Fairhead C, Gabaldón T (2019) Front Microbiol 10: 112 Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations.
105437591999Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J (1999) Antimicrob Agents Chemother 43: 2753-65 The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
286633422017Vale-Silva L, Beaudoing E, Tran VDT, Sanglard D (2017) G3 (Bethesda) 7: 2413-2426 Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates.
304781622019Barber AE, Weber M, Kaerger K, Linde J, Gölz H, Duerschmied D, Markert A, Guthke R, Walther G, Kurzai O (2019) Antimicrob Agents Chemother 63: Comparative Genomics of Serial Candida glabrata Isolates and the Rapid Acquisition of Echinocandin Resistance during Therapy.
277135002016Xu N, Ye C, Chen X, Liu J, Liu L, Chen J (2016) Sci Rep 6: 34893 Genome Sequencing of the Pyruvate-producing Strain Candida glabrata CCTCC M202019 and Genomic Comparison with Strain CBS138.
303486662019Cavalheiro M, Costa C, Silva-Dias A, Miranda IM, Wang C, Pais P, Pinto SN, Mil-Homens D, Sato-Okamoto M, Takahashi-Nakaguchi A, Silva RM, Mira NP, Fialho AM, Chibana H, Rodrigues AG, Butler G, Teixeira MC (2019) Antimicrob Agents Chemother 63: A Transcriptomics Approach To Unveiling the Mechanisms of In Vitro Evolution towards Fluconazole Resistance of a Candida glabrata Clinical Isolate.